Australian-owned company Troy Animal Healthcare is acquiring a range of products from multinational Elanco Animal Health in a deal that will bring onshore the manufacture of a number of Elanco’s sheep livestock brands.
Troy Animal Healthcare will add to its existing animal health portfolio with the acquisition of the rights to Elanco’s sheep livestock brands Avenge+Fly in Australia, and the Zapp Encore and Maggo sheep ecto parasite products in New Zealand.
Avenge+Fly is a leading treatment for sheep lice and blowfly strike prevention in Australia. Maggo and Zapp Encore sheep ecto parasite products are used extensively by primary producers in New Zealand for the treatment and prevention of flystrike.
The deal will see manufacturing of Avenge+Fly move from New Zealand to Troy’s western Sydney factory at Glendenning.
Troy Animal Healthcare Chief Executive Officer Nicolas Shortis said, “This is an important time for the Australian sheep industry as growers rebuild flocks following the drought and as the La Niña weather cycle contributes to the potential for increased flystrike.”
Troy’s current business plans include further development in the sheep parasiticide area as well as vitamin and mineral supplements. The company’s portfolio includes Vitamin ADE, a product which supports the health of sheep, cattle and pigs, Doramate, an injectable parasiticide product for cattle and pigs, and Buccalgesic, an animal welfare product which is used to provide pain relief for cattle and sheep during animal husbandry procedures.
For more information go to: www.troylab.com.au.